Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Cp (NQ: TECH )

78.68 -2.51 (-3.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 837,760
Open 80.76
Bid (Size) 77.01 (1)
Ask (Size) 80.00 (2)
Prev. Close 81.19
Today's Range 78.55 - 80.94
52wk Range 77.87 - 455.22
Shares Outstanding 39,242,384
Dividend Yield 1.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Health Care Stocks That Are Diving - And May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga

Performance

YTD
-4.66%
-4.66%
1 Month
-5.07%
-5.07%
3 Month
-73.44%
-73.44%
6 Month
-79.47%
-79.47%
1 Year
-79.10%
-79.10%

More News

Read More
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
Via Benzinga
Our 7 Top Biotech Stock Picks for 2023
Via InvestorPlace
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
Via Benzinga
Recap: Bio-Techne Q4 Earnings
Via Benzinga
Recap: Bio-Techne Q3 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
Via Benzinga
Bio-Techne: Q1 Earnings Insights
Via Benzinga
Bio-Techne Clocks 17% Organic Revenue Growth In Q2, Announces $400M Share Buyback
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Tackling Recurring Health Conditions Offers Hope to Patients
Via FinancialNewsMedia
Earnings Scheduled For November 1, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
7 Defensive Growth Stocks to Buy for a Shaky Market
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Via Benzinga
7 Superior Stocks That Smart Investors Will Buy on the Dip
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
Via Benzinga
Here's How Much You Would Have Made Owning Bio-Techne Stock In The Last 5 Years
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.